<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35129626</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>269</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Home-monitoring of vital capacity in people with a motor neuron disease.</ArticleTitle><Pagination><StartPage>3713</StartPage><EndPage>3722</EndPage><MedlinePgn>3713-3722</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-022-10996-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Home-monitoring of spirometry has the potential to improve care for patients with a motor neuron disease (MND) by enabling early detection of respiratory dysfunction and reducing travel burden. Our aim was to evaluate the validity and feasibility of home-monitoring vital capacity (VC) in patients with MND.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We included 33 patients with amyotrophic lateral sclerosis, progressive muscular atrophy or primary lateral sclerosis who completed a 12-week home-monitoring protocol, consisting of 4-weekly unsupervised home assessments of VC and a functional rating scale. At baseline, during a home visit, patients/caregivers were trained in performing a VC test, and the investigator performed a supervised VC test, which was repeated at final follow-up during a second home visit. Validity of the unsupervised VC tests was evaluated by the differences between supervised and unsupervised VC tests, and through Bland-Altman 95% limits-of-agreement. Feasibility was assessed by means of a survey of user-experiences.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The 95% limits-of-agreement were [-&#x2009;14.3; 11.7] %predicted VC, and 88% of unsupervised VC tests fell within 10%predicted of supervised VC. 88% of patients experienced VC testing as easy and not burdensome, however, 15% patients did not think their VC test was performed as well as in the clinic. 94% of patients would like home-monitoring of VC in MND care.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Unsupervised VC testing at home, with prior face-to-face training, is a valid and time-efficient method for the remote monitoring of respiratory function, and well-accepted by patients with MND and their caregivers.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Helleman</LastName><ForeName>Jochem</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science and Sports, UMC Utrecht Brain Center, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, and De Hoogstraat Rehabilitation, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakers</LastName><ForeName>Jaap N E</ForeName><Initials>JNE</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science and Sports, UMC Utrecht Brain Center, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pirard</LastName><ForeName>Evelien</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Revant Center for Rehabilitation, Breda, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Berg</LastName><ForeName>Leonard H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visser-Meily</LastName><ForeName>Johanna M A</ForeName><Initials>JMA</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science and Sports, UMC Utrecht Brain Center, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, and De Hoogstraat Rehabilitation, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beelen</LastName><ForeName>Anita</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1269-0710</Identifier><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science and Sports, UMC Utrecht Brain Center, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. j.a.j.beelen@umcutrecht.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, and De Hoogstraat Rehabilitation, Utrecht, The Netherlands. j.a.j.beelen@umcutrecht.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012119" MajorTopicYN="N">Respiration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013147" MajorTopicYN="N">Spirometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014797" MajorTopicYN="N">Vital Capacity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">Remote monitoring</Keyword><Keyword MajorTopicYN="N">Respiratory function</Keyword><Keyword MajorTopicYN="N">Validity</Keyword><Keyword MajorTopicYN="N">Vital capacity</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>7</Day><Hour>12</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35129626</ArticleId><ArticleId IdType="pmc">PMC9217878</ArticleId><ArticleId IdType="doi">10.1007/s00415-022-10996-1</ArticleId><ArticleId IdType="pii">10.1007/s00415-022-10996-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Burkhardt C, Neuwirth C, Sommacal A, Andersen PM, Weber M. Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients. PLoS ONE. 2017;12(5):1&#x2013;12. doi: 10.1371/journal.pone.0177555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177555</ArticleId><ArticleId IdType="pmc">PMC5441602</ArticleId><ArticleId IdType="pubmed">28542233</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Pradat PF, Salachas F, Bruneteau G, le Forestier N, Seilhean D, et al. Causes of death in a post-mortem series of ALS patients. Amyotroph Lateral Scler. 2008;9(1):59&#x2013;62. doi: 10.1080/17482960701656940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701656940</ArticleId><ArticleId IdType="pubmed">17924236</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS)&#x2014;revised report of an EFNS task force. Eur J Neurol. 2012;19:360&#x2013;375. doi: 10.1111/j.1468-1331.2011.03501.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE. Motor neurone disease: assessment and Motor neurone disease: assessment and management management NICE guideline [Internet]. 2016 [cited 2019 Aug 30]. Available from: www.nice.org.uk/guidance/ng42</Citation></Reference><Reference><Citation>Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew FD, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review) Neurology. 2009;73:1218&#x2013;1226. doi: 10.1212/WNL.0b013e3181bc0141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bc0141</ArticleId><ArticleId IdType="pmc">PMC2764727</ArticleId><ArticleId IdType="pubmed">19822872</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 2006;5(2):140&#x2013;147. doi: 10.1016/S1474-4422(05)70326-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(05)70326-4</ArticleId><ArticleId IdType="pubmed">16426990</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrijsen B, Buyse B, Belge C, Robberecht W, Van Damme P, Decramer M, et al. Noninvasive ventilation improves sleep in amyotrophic lateral sclerosis: a prospective polysomnographic study. J Clin Sleep Med. 2015;11(5):559&#x2013;566. doi: 10.5664/jcsm.4704.</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.4704</ArticleId><ArticleId IdType="pmc">PMC4410930</ArticleId><ArticleId IdType="pubmed">25766713</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustfa N, Walsh E, Bryant V, Lyall RA, Addington-Hall J, Goldstein LH, et al. The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology. 2006;66(8):1211&#x2013;1217. doi: 10.1212/01.wnl.0000208957.88534.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000208957.88534.11</ArticleId><ArticleId IdType="pubmed">16636239</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens HE, Young J, Felgoise SH, Simmons Z. A qualitative study of multidisciplinary ALS clinic use in the United States. Amyotroph Lateral Scler Front Degener. 2016;17(1&#x2013;2):55&#x2013;61. doi: 10.3109/21678421.2015.1069851.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1069851</ArticleId><ArticleId IdType="pubmed">26508132</ArticleId></ArticleIdList></Reference><Reference><Citation>Schellenberg KL, Hansen G. Patient perspectives on transitioning to amyotrophic lateral sclerosis multidisciplinary clinics. J Multidiscip Healthc. 2018;11:519&#x2013;524. doi: 10.2147/JMDH.S177563.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JMDH.S177563</ArticleId><ArticleId IdType="pmc">PMC6171753</ArticleId><ArticleId IdType="pubmed">30319269</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson E, Baird W, Bradburn M, Cooper C, Mawson S, Quinn A, et al. Process evaluation and exploration of telehealth in motor neuron disease in a UK specialist centre. BMJ Open. 2019;9(10):e028526. doi: 10.1136/bmjopen-2018-028526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-028526</ArticleId><ArticleId IdType="pmc">PMC6830641</ArticleId><ArticleId IdType="pubmed">31640994</ArticleId></ArticleIdList></Reference><Reference><Citation>Helleman J, Van Eenennaam R, Kruitwagen ET, Kruithof WJ, Slappendel MJ, Van Den Berg LH, et al. Telehealth as part of specialized ALS care: feasibility and user experiences with &#x201c;ALS home-monitoring and coaching&#x201d;. Amyotroph Lateral Scler Front Degener. 2020;21(3&#x2013;4):183&#x2013;192. doi: 10.1080/21678421.2020.1718712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1718712</ArticleId><ArticleId IdType="pubmed">32003245</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F, Cantello R, Ambrosini S, Mazzini L, Sarnelli MF, De Marchi I, et al. Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19. Neurol Sci. 2020;41(6):1365&#x2013;1367. doi: 10.1007/s10072-020-04457-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04457-8</ArticleId><ArticleId IdType="pmc">PMC7240164</ArticleId><ArticleId IdType="pubmed">32440978</ArticleId></ArticleIdList></Reference><Reference><Citation>Capozzo R, Zoccolella S, Musio M, Barone R, Accogli M, Logroscino G. Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy. Amyotroph Lateral Scler Front Degener. 2020;21(7&#x2013;8):542&#x2013;548. doi: 10.1080/21678421.2020.1773502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1773502</ArticleId><ArticleId IdType="pubmed">32530314</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkirk SM, Washington MO, McClellan F, Flynn B, Seton JM, Strozewski R. Delivering tertiary centre specialty care to ALS patients via telemedicine: a retrospective cohort analysis. Amyotroph Lateral Scler Front Degener. 2017;18(5&#x2013;6):324&#x2013;332. doi: 10.1080/21678421.2017.1313867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1313867</ArticleId><ArticleId IdType="pubmed">28427284</ArticleId></ArticleIdList></Reference><Reference><Citation>Van De Rijn M, Paganoni S, Levine-Weinberg M, Campbell K, Swartz Ellrodt A, Estrada J, et al. Experience with telemedicine in a multi-disciplinary ALS clinic. Amyotroph Lateral Scler Front Degener. 2018;19(1&#x2013;2):143&#x2013;148. doi: 10.1080/21678421.2017.1392577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1392577</ArticleId><ArticleId IdType="pubmed">29250986</ArticleId></ArticleIdList></Reference><Reference><Citation>Helleman J, Kruitwagen-van Reenen ET, Bakers J, Kruithof WJ, van Groenestijn AC, Jaspers Focks RJH, et al. Using patient-reported symptoms of dyspnea for screening reduced respiratory function in patients with motor neuron diseases. J Neurol. 2020 doi: 10.1007/s00415-020-10003-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10003-5</ArticleId><ArticleId IdType="pmc">PMC7578163</ArticleId><ArticleId IdType="pubmed">32577867</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumann F, Henderson RD, Morrison SC, Brown M, Hutchinson N, Douglas JA, et al. Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11(1&#x2013;2):194&#x2013;202. doi: 10.3109/17482960902991773.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902991773</ArticleId><ArticleId IdType="pubmed">19452343</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A, Vasta R, Moglia C, Matteoni E, Canosa A, Mattei A, et al. Prognostic role of slow vital capacity in amyotrophic lateral sclerosis. J Neurol. 2020;267(6):1615&#x2013;1621. doi: 10.1007/s00415-020-09751-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09751-1</ArticleId><ArticleId IdType="pubmed">32052165</ArticleId></ArticleIdList></Reference><Reference><Citation>Helleman J, Kruitwagen ET, van den Berg LH, Visser-Meily JMA, Beelen A. The current use of telehealth in ALS care and the barriers to and facilitators of implementation: a systematic review. Amyotroph Lateral Scler Front Degener. 2020;21(3&#x2013;4):167&#x2013;182. doi: 10.1080/21678421.2019.1706581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1706581</ArticleId><ArticleId IdType="pubmed">31878794</ArticleId></ArticleIdList></Reference><Reference><Citation>Tattersall R, Carty S, Meldrum D, Hardiman O, Murray D. The patient&#x2019;s perspective of remote respiratory assessments during the COVID-19 pandemic. Amyotroph Lateral Scler Front Degener. 2021 doi: 10.1080/21678421.2021.1920982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1920982</ArticleId><ArticleId IdType="pubmed">34092157</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L, Rudnicki SA, Lechtzin N, Cockroft B, Malik FI, Wolff AA, et al. Correlation between slow vital capacity measured in the home and in the clinic for patients with amyotrophic lateral sclerosis. Neurology. 2019;92(15 supplement):P4.4&#x2013;002.</Citation></Reference><Reference><Citation>Pellegrino GM, Sferrazza Papa GF, Centanni S, Corbo M, Kvarnberg D, Tobin MJ, et al. Measuring vital capacity in amyotrophic lateral sclerosis: effects of interfaces and reproducibility. Respir Med. 2021 doi: 10.1016/j.rmed.2020.106277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106277</ArticleId><ArticleId IdType="pubmed">33310203</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169(1&#x2013;2):13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk RPA, Bakers JNE, van Es MA, Eijkemans MJC, van den Berg LH. Implications of spirometric reference values for amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2019;20(7&#x2013;8):473&#x2013;80. doi: 10.1080/21678421.2019.1634736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1634736</ArticleId><ArticleId IdType="pubmed">31271047</ArticleId></ArticleIdList></Reference><Reference><Citation>Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3&#x2013;95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324&#x2013;1343. doi: 10.1183/09031936.00080312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00080312</ArticleId><ArticleId IdType="pmc">PMC3786581</ArticleId><ArticleId IdType="pubmed">22743675</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendoza M, Gelinas DF, Moore DH, Miller RG. A comparison of maximal inspiratory pressure and forced vital capacity as potential criteria for initiating non-invasive ventilation in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8(2):106&#x2013;111. doi: 10.1080/17482960601030188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960601030188</ArticleId><ArticleId IdType="pubmed">17453639</ArticleId></ArticleIdList></Reference><Reference><Citation>Geronimo A, Simmons Z. Evaluation of remote pulmonary function testing in motor neuron disease. Amyotroph Lateral Scler Front Degener. 2019;20(5&#x2013;6):348&#x2013;355. doi: 10.1080/21678421.2019.1587633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1587633</ArticleId><ArticleId IdType="pubmed">30957547</ArticleId></ArticleIdList></Reference><Reference><Citation>Simblett S, Greer B, Matcham F, Curtis H, Polhemus A, Ferr&#xe3;o J, et al. Barriers to and facilitators of engagement with remote measurement technology for managing health: systematic review and content analysis of findings. J Med Internet Res. 2018;20(7):e10480. doi: 10.2196/10480.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/10480</ArticleId><ArticleId IdType="pmc">PMC6062692</ArticleId><ArticleId IdType="pubmed">30001997</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards C, Costello E, Cassidy N, Vick B, Russell AM. Use of the patientMpower app with home-based spirometry to monitor the symptoms and impact of fibrotic lung conditions: longitudinal observational study. JMIR mHealth uHealth. 2020;8(11):1&#x2013;9. doi: 10.2196/16158.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/16158</ArticleId><ArticleId IdType="pmc">PMC7718088</ArticleId><ArticleId IdType="pubmed">33216007</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk RPA, Beelen A, Kruitwagen ET, Murray D, Radakovic R, Hobson E, et al. A road map for remote digital health technology for motor neuron disease. J Med Internet Res. 2021;23(9):e28766. doi: 10.2196/28766.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/28766</ArticleId><ArticleId IdType="pmc">PMC8495582</ArticleId><ArticleId IdType="pubmed">34550089</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CE, Rosenfeld J, Moore DH, Bryan WW, Barohn RJ, Wrench M, et al. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci. 2001;191:75&#x2013;78. doi: 10.1016/S0022-510X(01)00617-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00617-7</ArticleId><ArticleId IdType="pubmed">11676995</ArticleId></ArticleIdList></Reference><Reference><Citation>Elman LB, Siderowf AD, McCluskey LF. Nocturnal oximetry: utility in the respiratory management of amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2003;82(11):866&#x2013;870. doi: 10.1097/01.PHM.0000091985.22659.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.PHM.0000091985.22659.30</ArticleId><ArticleId IdType="pubmed">14566155</ArticleId></ArticleIdList></Reference><Reference><Citation>Panchabhai TS, Mireles Cabodevila E, Pioro EP, Wang X, Han X, Aboussouan LS. Pattern of lung function decline in patients with amyotrophic lateral sclerosis: implications for timing of noninvasive ventilation. ERJ Open Res. 2019;5(3):00044&#x2013;2019. doi: 10.1183/23120541.00044-2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00044-2019</ArticleId><ArticleId IdType="pmc">PMC6759589</ArticleId><ArticleId IdType="pubmed">31579678</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T, Ringer TM, Wullenkord K, Garrison P, Gunkel A, Stubendorff B, et al. Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation? J Neurol Neurosurg Psychiatry. 2016;87(9):1022&#x2013;1026. doi: 10.1136/jnnp-2015-312185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-312185</ArticleId><ArticleId IdType="pmc">PMC5013137</ArticleId><ArticleId IdType="pubmed">27010615</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt EP, Drachman DB, Wiener CM, Clawson L, Kimball R, Lechtzin N. Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design. Muscle Nerve. 2006;33(1):127&#x2013;132. doi: 10.1002/mus.20450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20450</ArticleId><ArticleId IdType="pubmed">16258948</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechtzin N, Wiener CM, Shade DM, Clawson L, Diette GB. Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis. Chest. 2002;121:436&#x2013;442. doi: 10.1378/chest.121.2.436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.121.2.436</ArticleId><ArticleId IdType="pubmed">11834654</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrat&#xfa; P, Cassano A, Gadaleta F, Tedone M, Dongiovanni S, Fanfulla F, et al. Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis: preliminary results. Amyotroph Lateral Scler. 2011;12(6):458&#x2013;463. doi: 10.3109/17482968.2011.593038.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.593038</ArticleId><ArticleId IdType="pubmed">21745123</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>